期刊文献+

ICU多耐药肺炎克雷伯菌整合子及耐药基因研究

Study on integrons and drug-resistant genes of multidrug resistant Klebsiella pneumoniae in ICU
原文传递
导出
摘要 目的研究ICU多耐药肺炎克雷伯菌的整合子及其耐药基因情况。方法收集宁波市医疗中心李惠利医院2019年ICU来源多耐药肺炎克雷伯菌30株,统计分析药敏结果;多重PCR检测Ⅰ类、Ⅱ类、Ⅲ类整合酶基因及整合子可变区,进一步对整合子阳性菌株的可变区进行测序分析。结果30株多耐药肺炎克雷伯菌对多种抗菌药物(头孢类头孢唑林、头孢曲松,氨基糖苷类阿米卡星、庆大霉素,磺胺类甲氧苄氨嘧啶)的耐药率均超过70%;均检出Ⅰ类整合酶基因,未检出Ⅱ类、Ⅲ类整合酶基因;23株菌基因盒PCR扩增阳性,扩增片段大小为1904 bp~1929 bp,均为dfrA12-orf-aadA2基因盒。结论本地区ICU多耐药肺炎克雷伯菌很可能普遍含有Ⅰ类整合子及基因盒dfrA12-orf-aadA2,需加强耐药监测合理使用抗菌药物。 Objective To study the integrons and drug-resistant genes of multidrug resistant Klebsiella pneumonia(K.pneumoniae)in ICU.Methods In total,30 strains of multi-drug resistance K.pneumonia were collected in Ningbo Medical Center Lihuili Hospital.The classⅠ,Ⅱ,Ⅲintegrons and the variable regions of integrons were analyzed by PCR and sequencing.Results The drug resistance rate of 30 strains of multidrug-resistant Klebsiella pneumoniae to multiple antibiotics(cefazolin,ceftriaxone,aminoglycoside amikacin,gentamicin,sulfamethoprim)was more than 70%.Ⅰclass integrase genes were detected,butⅡ,Ⅲintegrase genes were not detected;the 23 strains were positive for PCR amplification,and the size of the amplified fragments ranged from 1904 bp to 1929 bp,all of which were dfrA12-ORF-aadA2 gene boxes.Conclusion ICU multi-drug resistance K.pneumonia carry classⅠintegron and dfrA12-orf-aadA2 resistance gene cassettes in this area,and the monitoring of drug resistance strains should be strengthened.
作者 张恩 李霞 ZHANG En;LI Xia(Clinical Laboratory,Ningbo Medical Center Lihuili Hospital,Ningbo,Zhejiang 315040,China)
出处 《中国卫生检验杂志》 CAS 2021年第7期820-822,共3页 Chinese Journal of Health Laboratory Technology
基金 宁波市自然科学基金项目(2017A610280)。
关键词 多耐药肺炎克雷伯菌 耐药性 整合子 耐药基因 Multidrug-resistant Klebsiella pneumoniae Drug resistance Integron Drug resistance genes
  • 相关文献

参考文献7

二级参考文献38

  • 1杜艳,陈玲玲,邵天波,陈端.克雷伯菌临床菌株中1类整合子相关基因的分析[J].昆明医学院学报,2005,26(1):17-19. 被引量:13
  • 2石磊,陈洵,肖增璜.多重耐药临床菌株中整合子结构的检测与分析[J].中国抗生素杂志,2007,32(1):43-48. 被引量:24
  • 3李涛,卢义柱,凌华志,徐元宏,王中新,熊自忠.肺炎克雷伯菌Ⅱ类整合子的分布及结构分析[J].临床输血与检验,2007,9(3):197-199. 被引量:6
  • 4Molton JS,Tambyah PA,Ang BS,et al.The global spread of healthcare-associated multidrug-resistant bacteria:aperspective from Asia[J].Clin Infect Dis,2013,56(9):1310-1318.
  • 5Chen LF,Anderson DJ,Paterson DL.Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases(KPC)resistance[J].Infect Drug Resist,2012,5:133-141.
  • 6Cuzon G,Naas T,Truong H,et al.Worldwide diversity of Klebsiella pneumoniae that produceβ-lactamase blaKPC-2Gene[J].Emerg Infect Dis,2010,16(9):1349-1356.
  • 7Nordmann P.Carbapenemase-producing Enterobacteriaceae:overview of a major public health challenge[J].Med Mal Infect,2014,44(2):51-56.
  • 8K.Hussein,A Raz-Pasteur,R.Finkelstein,et al.Impact of carbapenem resistance on the outcome of patients'hospital-acquired bacteraemia caused by Klebsiella pneumoniae[J].J Hosp Infect,2013,83:307-313.
  • 9van der Zwaluw K,de Haan A,Pluister GN,et al.The carbapenem inactivation method(CIM),a simple and low-cost alternative for the Carb NP test to assess phenotypic carbapenemase activity in gram-negative rods[J].PloS ONE,2015,10(3):e0123690.
  • 10Gupta N,Limbago BM,Patel JB,et al.Carbapenem-resistant Enterobacteriaceae:epidemiology and prevention[J].Clin Infect Dis,2011,53(1):60-67.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部